Lonza cord blood CD34+ HLA cells (2C-101H) contain 1 million hematopoietic stem and progenitor cells, and are ideal for studies relating to transplantation and stem cells. They are also widely used in humanized mouse model development. Cord blood derived CD34+ HLA cells (2C-101H) is available with HLA information enabling prescreening and selection of lots most appropriate for your study, providing cost and time savings. HLA information eliminates the need to use cells for obtaining HLA genotype increasing the number of cells that can be used within your experiment. CD34+ HLA cells are ethically sourced and are isolated using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. Large inventory supports stable supply from a single vendor. Guarantee Lonza guarantees the performance of Cells only if appropriate Lonza recommended Media and Reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees.